BRAF and thyroid gland carcinoma: Thyroid cancer showed an enrichment of the somatic melanoma driver mutation BRAF(p.V600E) that surpassed profiles of BRAF of any other tissue (Figure 3–4), while preserving mutually exclusive setting to RAS mutations (Supplementary table 6).